TAILORx Trial Shows Women at Low Risk for Breast Cancer Recurrence May Forgo Chemotherapy

A summary of results from the Trial Assigning Individualized Options for Treatment, or TAILORx, finds that women with early-stage hormone receptor-positive breast cancer have a low risk of recurrence based on a test for the expression of 21 genes.

Media Type: Html
  • SourceUrl: https://www.cancer.gov/node/1004820/syndication
  • Syndication ID: 3651
  • Language: English
  • Source: National Cancer Institute (NCI)
  • Date Syndication Captured: Tuesday, September 29, 2015 at 01:00 AM
  • Date Syndication Updated: Monday, August 05, 2019 at 07:39 PM


General: breast cancer TAILORx oncotype dx hormone receptor-positive recurrence hormone therapy

Preview   0 Users liked this content.

Embed Code Snippet

To get the embed code snippet please Login.